Skip to Main Content

Paper Details

Identification of pathogenic variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment.
0
2023
C-peptide, DD2, HbA1c, Participants, T2D, benign variants, diabetes, glucokinase gene, glucose, hyperglycemia, metformin, monogenic diabetes, participant, participants, patients, rare variants, type 2 diabetes
Author NameAffiliation
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Niels GrarupNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Anette P GjesingNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
  • 1 - 4

Datasets

Release 1.2